华熙生物：关于2025年第三季度计提大额资产减值准备的公告

Core Viewpoint - Huaxi Biological announced the provision for asset impairment losses based on the principles of prudence, in accordance with the accounting standards set by the Ministry of Finance [2] Summary by Relevant Categories Financial Performance - For the third quarter of 2025, the company made a provision for bad debts amounting to 18.7159 million yuan for accounts receivable and reversed bad debt provisions of 1.1781 million yuan for other receivables, resulting in a total bad debt provision of 17.5378 million yuan [2]